Ginsberg, Henry N.
Tuomilehto, Jaakko
Hovingh, G. Kees
Cariou, Bertrand
Santos, Raul D.
Brown, Alan S.
Sanganalmath, Santosh K.
Koren, Andrew
Thompson, Desmond
Raal, Frederick J.
Funding for this research was provided by:
Sanofi
Regeneron Pharmacetucials, Inc.
Article History
First Online: 8 February 2019
Compliance with Ethical Standards
:
: Henry N. Ginsberg has received research grants from Amgen, Merck, Sanofi, and Regeneron Pharmaceuticals, Inc.; and is a consultant on advisory boards for Amgen, Janssen, Lilly, Merck, Novartis, Reserlogix, Sanofi, and Regeneron Pharmaceuticals, Inc. Jaakko Tuomilehto has received research grants from Bayer, Merck, Pfizer, and Sanofi; and has received honoraria and is a consultant on advisory boards for Bayer, Novo Nordisk, and Sanofi. G. Kees Hovingh has received research grants from the Netherlands Organization for Scientific Research, the CardioVascular Research Initiative, and the European Union; has received other research support from Aegerion, Amgen, and Sanofi; has participated in speakers bureau for Amgen, Aegerion, Sanofi, Regeneron Pharmaceuticals, Inc., and Pfizer; and is a consultant on advisory boards for Amgen, Aegerion, Sanofi, Regeneron Pharmaceuticals, Inc., and Pfizer. Bertrand Cariou has received research grants from Sanofi, Regeneron Pharmaceuticals, Inc., and Pfizer; has participated in speakers bureau for Amgen, AstraZeneca, Pierre Fabre, Eli Lilly, Novo Nordisk, MSD, Sanofi, and Regeneron Pharmaceuticals, Inc.; and is a consultant on advisory boards for Amgen, Novo-Nordisk and Sanofi, Regeneron Pharmaceuticals, Inc. Raul D. Santos has received research grants from Amgen and Ionis; has participated in speakers bureau for Amgen, AstraZeneca, Biolab, Sanofi, and Regeneron Pharmaceuticals, Inc.; and is a consultant on advisory boards for Akcea, Amgen, AstraZeneca, Biolab, Kowa, Merck, Novo Nordisk, Sanofi, and Regeneron Pharmaceuticals, Inc. Alan S. Brown has participated in speakers bureau for Amgen, Sanofi, and Regeneron Pharmaceuticals, Inc.; and is a consultant on advisory boards for Amarin, Amgen, Kastle, Kowa, Merck, Pfizer, and Regeneron Pharmaceuticals, Inc. Santosh K. Sanganalmath is an employee of and stockholder in Regeneron Pharmaceuticals, Inc. Andrew Koren is an employee of and stockholder in Sanofi. Desmond Thompson is a consultant to Medical Affairs at Regeneron Pharmaceuticals, Inc. Frederick J. Raal has received research grants from Amgen, Sanofi, and Regeneron Pharmaceuticals, Inc.; participated in speakers bureau for and received honoraria from Amgen, Sanofi, Regeneron Pharmaceuticals, Inc., and the Medicines Company; and is a consultant on advisory boards for Amgen, Sanofi, Regeneron Pharmaceuticals, Inc., and the Medicines Company.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.